Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Overview on etiopathogenesis of atopic dermatitis (CROSBI ID 739532)

Prilog sa skupa u časopisu | stručni rad

Lipozenčić Jasna ; Paštar, Zrinjka ; Ljubojević, Suzana ; Batinac, Tanja Overview on etiopathogenesis of atopic dermatitis // Acta Dermatovenerologica Croatica. 2004. str. 118-119-x

Podaci o odgovornosti

Lipozenčić Jasna ; Paštar, Zrinjka ; Ljubojević, Suzana ; Batinac, Tanja

engleski

Overview on etiopathogenesis of atopic dermatitis

In the etiopathogenesis of atopic dermatitis (AD) there are well known interactions among genetic, environmental, skin barrier, pharmacologic, stress and other emotional problems and immune factors.Genetic determinate of expression of AD as a pure or mixed with concomitant respiratory or intestine allergy depends on genetic susceptibility. Although many genes are involved in the development of allergic diseases, there has been particular interest in chromosome 5q31-33, 3q21, 1q21 and 17q25.Immunologic abnormalities of type I and type IV reactions have been described in patients with AD. Immunologic triggers are aeroallergens, food allergens, microbial products, and autoallergens and contact allergens. The immunologic reactions determinate many features of AD, as well as a cell mediated or delayed hypersensitivity. Type 2 (TH2) and type 1 (TH1) cytokines contribute to the pathogenesis of skin inflammation in AD. The currently accepted model proposes a predominant TH2 cytokine milieu in the initiating stages or acute lesions of AD and a mixed TH1 and TH2 pattern in chronic lesions. This biphasic pattern of T cell activation has been demonstrated after epicutaneous application of aeroallergens using patch-test. After 24 hours increased expression of IL-4 mRNA and protein ; IL-5, IL-13 is observed, after which IL-4 expression declines to base levels. In contrast, IFN-γ mRNA is strongly expressed at the 48- to 72-h time points as development of TH1 lymphocytes is mediated by the cytokines IFN-γ and IL-2. Type 2 cytokines are thought to account for coincident eosinophilia and elevate IgE production and attraction of macrophages, which in turn produce IL-12, a known activator of the TH1-type immune response which suppress IgE production. So, AD skin contains an increased number of IgE-bearing Langerhans cells (LC) that, via the high-affinity IgE receptor FCє R1, is thought to bind allergens, as a major IgE binding receptor as there are several types of these receptors. LC play important role in cutaneous allergens presentation to TH2 cells via major histocompatibility molecules. These bridgings trigger a cascade of immunologic events. In chronic AD lesions LC are present in increased numbers and have increased amounts of IgE bound to high-affinity surface receptors. LC have been shown to be hyperstimulatory to helper T cells and can activate helper T cells to the TH2 phenotype in the initiating phase of the disease. Degranulation of eosinophils occurs in the dermis with the release of toxic proteins like major basic protein and could account for much of the inflammation. Mast cells are increased in number and produce mediators other than histamine that induce pruritus, and may have as effect on IFN-γ expression. Mast cells cytokines IL-4 and IL-13 are important for IgE production and mast cell chymase may induce eosinophil infiltration into AD lesional skin. There is elevated production of prostaglandin E2 (PGE2) by peripheral monocytes. Prostaglandin E2 (PGE2) has at least two potential roles in the initiation of AD. Firstly, it reduces IFN-γ production from helper T cells and thereby favoring initial, dominant TH2 immune response and, secondly, it directly enhances IgE production by B lymphocytes by increased secretion of IL-4, IL-5 and IL-13. Many lesions of AD result from scratching thereby it is tempting to speculate that immune perturbations in genetically predisposed individuals provoke the release of local pruritogens and keratinocyte-derived cytokines further drive the previously described immune response.

etiopathogenesis of atopic dermatitis; genetic; environmental; skin barrier; pharmacologic; stress; emotional problems and immune factors

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

118-119-x.

2004.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Acta Dermatovenerologica Croatica

1330-027X

Podaci o skupu

Nepoznat skup

ostalo

29.02.1904-29.02.2096

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost